According to S&S Insider, the global Inhalation Anesthesia Market was valued at USD 1.69 billion in 2024 and is projected to reach USD 2.82 billion by 2032, growing at a CAGR of 6.66% over 2025–2032.

Zion Market Research has published a new report titled “Inhalation Anesthesia Market By Product (Desflurane, Isoflurane, Sevoflurane, and Others), By End-User (Hospitals & Clinics, Ambulatory Surgical ...

New York, March 03, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Inhalation Sedatives Global Market Report 2022" - https://www ...

Intravenous (i.v.) anesthetics include etomidate, midazolam, propofol, thiopental, ketamine, and opioid agonists. The first four agents act by enhancing the activity of the inhibitory neurotransmitter ...

Is there any difference in postoperative morbidities for 24 h following dental care under day-stay general anaesthesia using sevoflurane or halothane in intellectually disabled children? Children were ...

AUSTIN, Texas--(BUSINESS WIRE)--TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its ...

Adult: Inhalation Induction- 2-4% v/v in O2 or mixtures of nitrous oxide and O2. Maintenance: 0.5-2% v/v depending on the flow rate used.